LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process

Cancer Letters

Volumn 347, Issue 2, 2014, Pages 225-232

  Qin, Yi ^a,b   Zhu, Wenwei ^a,b   Xu, Wenyan ^a,b   Zhang, Bo ^a,b   Shi, Si ^a,b   Ji, Shunrong ^a,b   Liu, Jiang ^a,b   Long, Jiang ^a,b   Liu, Chen ^a,b   Liu, Liang ^a,b   Xu, Jin ^a,b   Yu, Xianjun ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Glycolysis; HIF1 ; LSD1; Pancreatic cancer

Indexed keywords

GLYCOLYSIS; HIF1Α; LSD1; PANCREATIC CANCER;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; FEMALE; GLYCOLYSIS; HISTONE DEMETHYLASES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84898405029     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.02.013     Document Type: Article

References (37)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63:11-30.
2. Vincent A., Herman J., Schulick R., Hruban R.H., Goggins M. Pancreatic cancer. Lancet 2011, 378:607-620.
3. Shi S., Yao W., Xu J., Long J., Liu C., Yu X. Combinational therapy: new hope for pancreatic cancer?. Cancer Lett. 2012, 317:127-135.
4. McCleary-Wheeler A.L., Lomberk G.A., Weiss F.U., Schneider G., Fabbri M., Poshusta T.L., Dusetti N.J., Baumgart S., Iovanna J.L., Ellenrieder V., Urrutia R., Fernandez-Zapico M.E. Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis. Cancer Lett. 2013, 328:212-221.
5. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
6. Fukushige S., Horii A. Road to early detection of pancreatic cancer: attempts to utilize epigenetic biomarkers. Cancer Lett. 2014, 342:231-237.
7. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., Casero R.A., Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-953.
8. Culhane J.C., Cole P.A. LSD1 and the chemistry of histone demethylation. Curr. Opin. Chem. Biol. 2007, 11:561-568.
9. Wang Y., Zhang H., Chen Y., Sun Y., Yang F., Yu W., Liang J., Sun L., Yang X., Shi L., Li R., Li Y., Zhang Y., Li Q., Yi X., Shang Y. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009, 138:660-672.
10. Ouyang H., Qin Y., Liu Y., Xie Y., Liu J. Prox1 directly interacts with LSD1 and recruits the LSD1/NuRD complex to epigenetically co-repress CYP7A1 transcription. PLoS ONE 2013, 8:e62192.
11. Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N., Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N., Beisenherz-Huss C., Gunther T., Buettner R., Schule R. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. Nature 2010, 464:792-796.
12. Greenberg E.S., Chong K.K., Huynh K.T., Tanaka R., Hoon D.S. Epigenetic biomarkers in skin cancer. Cancer Lett. 2014, 342:170-177.
13. Kahl P., Gullotti L., Heukamp L.C., Wolf S., Friedrichs N., Vorreuther R., Solleder G., Bastian P.J., Ellinger J., Metzger E., Schule R., Buettner R. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res. 2006, 66:11341-11347.
14. Schulte J.H., Lim S., Schramm A., Friedrichs N., Koster J., Versteeg R., Ora I., Pajtler K., Klein-Hitpass L., Kuhfittig-Kulle S., Metzger E., Schule R., Eggert A., Buettner R., Kirfel J. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res. 2009, 69:2065-2071.
15. Hayami S., Kelly J.D., Cho H.S., Yoshimatsu M., Unoki M., Tsunoda T., Field H.I., Neal D.E., Yamaue H., Ponder B.A., Nakamura Y., Hamamoto R. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int. J. Cancer 2011, 128:574-586.
16. Kauffman E.C., Robinson B.D., Downes M.J., Powell L.G., Lee M.M., Scherr D.S., Gudas L.J., Mongan N.P. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol. Carcinog. 2011, 50:931-944.
17. Lim S., Janzer A., Becker A., Zimmer A., Schule R., Buettner R., Kirfel J. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010, 31:512-520.
18. Koong A.C., Denko N.C., Hudson K.M., Schindler C., Swiersz L., Koch C., Evans S., Ibrahim H., Le Q.T., Terris D.J., Giaccia A.J. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 2000, 60:883-887.
19. Bristow R.G., Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer 2008, 8:180-192.
20. Taddei M.L., Giannoni E., Comito G., Chiarugi P. Microenvironment and tumor cell plasticity: an easy way out. Cancer Lett. 2013, 341:80-96.
21. Zhou J., Schmid T., Schnitzer S., Brune B. Tumor hypoxia and cancer progression. Cancer Lett. 2006, 237:10-21.
22. Cheng J.C., Klausen C., Leung P.C. Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. Cancer Lett. 2013, 329:197-206.
23. Denko N.C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 2008, 8:705-713.
24. Liu Y., Zhang J.B., Qin Y., Wang W., Wei L., Teng Y., Guo L., Zhang B., Lin Z., Liu J., Ren Z.G., Ye Q.H., Xie Y. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1alpha expression and protein stability. Hepatology 2013, 58:692-705.
25. Chang C.C., Lin B.R., Chen S.T., Hsieh T.H., Li Y.J., Kuo M.Y. HDAC2 promotes cell migration/invasion abilities through HIF-1alpha stabilization in human oral squamous cell carcinoma. J. Oral Pathol. Med.: Off. Publ. Int. Assoc. Oral Patholog. Am. Acad. Oral Pathol. 2011, 40:567-575.
26. Xu J., Zhu W., Xu W., Cui X., Chen L., Ji S., Qin Y., Yao W., Liu L., Liu C., Long J., Li M., Yu X. Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair. Int. J. Oncol. 2013, 42:2046-2052.
27. Cheng H., Li J., Liu C., Yao W., Xu Y., Frank T.S., Cai X., Shi S., Lu Y., Qin Y., Liu L., Xu J., Long J., Ni Q.X., Li M., Yu X.J. Profilin1 sensitizes pancreatic cancer cells to irradiation by inducing apoptosis and reducing autophagy. Curr. Mol. Med. 2013, 13:1368-1375.
28. Xu J., Zhu W., Xu W., Yao W., Zhang B., Xu Y., Ji S., Liu C., Long J., Ni Q., Yu X. Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin. Curr. Mol. Med. 2013, 13:387-400.
29. Geng H., Harvey C.T., Pittsenbarger J., Liu Q., Beer T.M., Xue C., Qian D.Z. HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia. J. Biol. Chem. 2011, 286:38095-38102.
30. Piret J.P., Mottet D., Raes M., Michiels C. CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann. N. Y. Acad. Sci. 2002, 973:443-447.
31. Scoumanne A., Chen X. The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners. J. Biol. Chem. 2007, 282:15471-15475.
32. Keith B., Johnson R.S., Simon M.C. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer 2012, 12:9-22.
33. Yoo Y.G., Na T.Y., Seo H.W., Seong J.K., Park C.K., Shin Y.K., Lee M.O. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008, 27:3405-3413.
34. Amente S., Lania L., Majello B. The histone LSD1 demethylase in stemness and cancer transcription programs. Biochim. Biophys. Acta 1829, 2013:981-986.
35. Guillaumond F., Leca J., Olivares O., Lavaut M.N., Vidal N., Berthezene P., Dusetti N.J., Loncle C., Calvo E., Turrini O., Iovanna J.L., Tomasini R., Vasseur S. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc. Nat. Acad. Sci. U.S.A. 2013, 110:3919-3924.
36. Voss M.J., Niggemann B., Zanker K.S., Entschladen F. Tumour reactions to hypoxia. Curr. Mol. Med. 2010, 10:381-386.
37. Gort E.H., Groot A.J., van der Wall E., van Diest P.J., Vooijs M.A. Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr. Mol. Med. 2008, 8:60-67.